Nektar(NKTR) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Nektar Therapeutics Reports First Quarter 2024 Financial Results SAN FRANCISCO, May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024. Cash and investments in marketable securities at March 31, 2024 were $326.0 million as compared to$329.4 million at December 31, 2023. Nektar's cash and marketable securities are expected to support strategic development activities and operations into the third quarter of 2026. ...